These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7053285)

  • 1. The 24-hour ambulatory blood pressure profile with verapamil.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Circulation; 1982 Jan; 65(1):22-7. PubMed ID: 7053285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Subramanian VB; Raftery EB
    Acta Med Scand Suppl; 1984; 681():117-23. PubMed ID: 6587750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():113-21. PubMed ID: 6956472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine or verapamil as sole treatment of hypertension. An intraarterial study.
    Gould BA; Hornung RS; Mann S; Subramanian VB; Raftery EB
    Hypertension; 1983; 5(4 Pt 2):II91-6. PubMed ID: 6862589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-daily verapamil for hypertension: a comparison with propranolol.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol versus verapamil for the treatment of essential hypertension.
    Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
    Am Heart J; 1984 Sep; 108(3 Pt 1):554-60. PubMed ID: 6382991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sustained-release verapamil on 24-hour ambulatory blood pressure and on pressor response to isometric exertion in hypertensive patients.
    Cardillo C; Musumeci V; Mores N; Folli G
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S31-3. PubMed ID: 2475681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a calcium antagonist: verapamil on resting blood pressure and pressor response to dynamic exercise.
    Herpin D; Amiel A; Boutaud P; Wajman A; Demange J
    Acta Cardiol; 1985; 40(3):277-90. PubMed ID: 3895793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V; Bonaduce D; De Caprio L; Nicolino A; Forgione L; Petretta M; Rengo F
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.
    Caruana M; Heber M; Brigden G; Raftery EB
    Eur J Clin Pharmacol; 1987; 32(6):549-53. PubMed ID: 3653223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and renal effects of orally administered verapamil.
    Leonetti G; Sala C; Bianchini C; Terzoli L; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):375-82. PubMed ID: 7002568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt sensitivity and the blood pressure response to verapamil.
    Weinberger MH; Wagner UL; Fineberg NS
    Am J Hypertens; 1994 Jun; 7(6):515-9. PubMed ID: 7917149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
    Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
    J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil in antihypertensive treatment of patients on renal replacement therapy--clinical implications and pharmacokinetics.
    Beyerlein C; Csaszar G; Hollmann M; Schumacher A
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S35-7. PubMed ID: 2261942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
    Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
    Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.